Durable clinical benefit in metastatic renal cell carcinoma patients who discontinue PD-1/PD-L1 therapy for immune-related adverse events (irAEs).
| Image |  |
|---|---|
| Description | scientific article published in February 2018 |
| Author/s |
author: Dylan J Martini Toni K Choueiri Aly-Khan Lalani Dominick Bossé |
| Publication date | February 1, 2018 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |